S&P 500
5.011,12 -11,09 (-0,22%) Nasdaq
15.601,50 -81,87 (-0,52%) NIKKEI 225
36.818,81 -1.260,89 (-3,31%) Dólar/Euro
1,0624 -0,0023 (-0,21%) Petróleo Brent
90,67 +3,56 (+4,09%) Bitcoin EUR
57.846,99 -268,20 (-0,46%)
Fresenius SE & Co. KGaA (FSNUF)
Fresenius SE & Co. KGaA
Else-Kroener-Strasse 1
Bad Homburg vor der Höhe 61352
Germany
49 6172 6080
https://www.fresenius.com
Sector(es): Healthcare
Sector: Medical Care Facilities
Empleados a tiempo completo: 193.865
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Michael Sen | CEO, President & Chairman of Management Board - Fresenius Management SE | 4,36M | N/A | 1968 |
| Ms. Sara Lisa Hennicken | CFO & Member of the Management Board - Fresenius Management SE | 1,65M | N/A | 1980 |
| Mr. Pierluigi Antonelli | Member of Management Board of Fresenius Management SE & CEO of Fresenius Kabi | 2,14M | N/A | N/A |
| Dr. Michael Sven Moser Ph.D. | Member of Management Board of Fresenius Management SE | 1,28M | N/A | 1978 |
| Mr. Robert Moller | Member of the Management Board of Fresenius Management SE | 1,23M | N/A | 1971 |
| Mr. Markus Georgi | Senior Vice President of Investor Relations | N/A | N/A | N/A |
| Matthias Link | Senior Vice President Corporate Communications | N/A | N/A | N/A |
Descripción
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Gobierno corporativo
El ISS Governance QualityScore de Fresenius SE & Co. KGaA, a día 1 de abril de 2024, es 2. Las puntuaciones base son Auditoría: 1; Tablero: 3; Derechos de los accionistas: 1; Compensación: 2.
